Liangchun Yang

2.7k total citations · 2 hit papers
36 papers, 2.0k citations indexed

About

Liangchun Yang is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Liangchun Yang has authored 36 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Hematology. Recurrent topics in Liangchun Yang's work include Advanced Glycation End Products research (7 papers), Autophagy in Disease and Therapy (6 papers) and Acute Myeloid Leukemia Research (5 papers). Liangchun Yang is often cited by papers focused on Advanced Glycation End Products research (7 papers), Autophagy in Disease and Therapy (6 papers) and Acute Myeloid Leukemia Research (5 papers). Liangchun Yang collaborates with scholars based in China, United States and Taiwan. Liangchun Yang's co-authors include Minghua Yang, Daolin Tang, Lizhi Cao, Rui Kang, Min Xie, Michael T. Lotze, Yu Yan, Timothy R. Billiar, Haichao Wang and Fanghua Ye and has published in prestigious journals such as Nature Communications, Blood and Biochemical Pharmacology.

In The Last Decade

Liangchun Yang

33 papers receiving 2.0k citations

Hit Papers

PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflamm... 2015 2026 2018 2022 2016 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation
    2016 432 citations Min Xie, Yan Yu et al. Nature Communications profile →
  2. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents
    2015 390 citations Yu Yan, Yangchun Xie et al. Molecular & Cellular Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangchun Yang China 16 1.1k 616 593 550 372 36 2.0k
Ding‐Sheng Jiang China 29 1.5k 1.3× 750 1.2× 885 1.5× 385 0.7× 237 0.6× 64 2.4k
Fei Quan China 10 1.2k 1.1× 771 1.3× 882 1.5× 419 0.8× 98 0.3× 23 2.1k
Jianjun Zhu China 21 1.2k 1.1× 357 0.6× 162 0.3× 282 0.5× 251 0.7× 59 1.8k
Rachida S. BelAiba Germany 15 822 0.7× 632 1.0× 215 0.4× 448 0.8× 156 0.4× 18 2.0k
Sangbin Lim South Korea 18 793 0.7× 258 0.4× 311 0.5× 335 0.6× 147 0.4× 32 1.6k
Gabrielle Paulsson‐Berne Sweden 32 1.2k 1.0× 442 0.7× 329 0.6× 1.2k 2.2× 537 1.4× 57 3.0k
Tomonori Sasahira Japan 31 1.7k 1.5× 804 1.3× 253 0.4× 425 0.8× 121 0.3× 85 2.9k
Zhenyu Cai China 15 1.6k 1.4× 495 0.8× 448 0.8× 596 1.1× 290 0.8× 19 2.1k

Countries citing papers authored by Liangchun Yang

Since Specialization
Citations

This map shows the geographic impact of Liangchun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangchun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangchun Yang more than expected).

Fields of papers citing papers by Liangchun Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangchun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangchun Yang. The network helps show where Liangchun Yang may publish in the future.

Co-authorship network of co-authors of Liangchun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Liangchun Yang. A scholar is included among the top collaborators of Liangchun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangchun Yang. Liangchun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Fang, Yongjun, Jie Yan, Ju Gao, et al.. (2024). The Prognostic and Risk Factors for Children With High‐Risk Mature B‐Cell Non‐Hodgkin's Lymphoma: A Retrospective Multicenter Study. Cancer Medicine. 13(21). e70309–e70309. 1 indexed citations
4.
Dong, Jiajia, Zhou Xu, Xia Guo, et al.. (2024). Effect of rituximab on immune status in children with aggressive mature B-cell lymphoma/leukemia–a prospective study from CCCG-BNHL-2015. Heliyon. 10(5). e27305–e27305. 1 indexed citations
5.
6.
Ye, Fanghua, et al.. (2023). Screening and validating circular RNAs that estimate disease risk and treatment response of pediatric acute myeloid leukemia: a microarray-based analyses and RT-qPCR validation. Journal of Cancer Research and Clinical Oncology. 149(13). 11233–11245. 2 indexed citations
7.
8.
Ye, Fanghua, Wen Zhang, Jiajia Dong, et al.. (2022). A novel STAT1 loss-of-function mutation associated with Mendelian susceptibility to mycobacterial disease. Frontiers in Cellular and Infection Microbiology. 12. 1002140–1002140. 9 indexed citations
9.
10.
Yang, Liangchun, Fanghua Ye, Li Zeng, Yanling Li, & Wenwen Chai. (2020). <p>Knockdown of HMGB1 Suppresses Hypoxia-Induced Mitochondrial Biogenesis in Pancreatic Cancer Cells</p>. OncoTargets and Therapy. Volume 13. 1187–1198. 9 indexed citations
11.
Chai, Wenwen, Fanghua Ye, Li Zeng, Yanling Li, & Liangchun Yang. (2019). HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells. Journal of Experimental & Clinical Cancer Research. 38(1). 325–325. 62 indexed citations
12.
Liu, Yingting, Pan Chen, Linyong Xu, et al.. (2019). Extracellular HMGB1 prevents necroptosis in acute myeloid leukemia cells. Biomedicine & Pharmacotherapy. 112. 108714–108714. 23 indexed citations
13.
Deng, Wenjun, Minghua Yang, Feimei Kuang, et al.. (2017). Blastic plasmacytoid dendritic cell neoplasm in children: A review of two cases. Molecular and Clinical Oncology. 7(4). 709–715. 5 indexed citations
14.
Xie, Min, Yan Yu, Rui Kang, et al.. (2016). PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation. Nature Communications. 7(1). 13280–13280. 432 indexed citations breakdown →
15.
Yang, Minghua, Liying Liu, Min Xie, et al.. (2015). Poly-ADP-ribosylation of HMGB1 regulates TNFSF10/TRAIL resistance through autophagy. Autophagy. 11(2). 214–224. 57 indexed citations
16.
Yan, Yu, Yangchun Xie, Lizhi Cao, et al.. (2015). The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Molecular & Cellular Oncology. 2(4). e1054549–e1054549. 390 indexed citations breakdown →
17.
Yang, Minghua, Lizhi Cao, Min Xie, et al.. (2013). Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis. Biochemical Pharmacology. 86(3). 410–418. 92 indexed citations
18.
Yang, Liangchun, Lizhi Cao, Minghua Yang, et al.. (2013). Hsp27: A novel therapeutic target for pediatric M4/M5 acute myeloid leukemia. Oncology Reports. 29(4). 1459–1466. 17 indexed citations
19.
Zhu, Shan, Lizhi Cao, Yan Yu, et al.. (2012). Inhibiting autophagy potentiates the anticancer activity of IFN1@/IFNα in chronic myeloid leukemia cells. Autophagy. 9(3). 317–327. 46 indexed citations
20.
Yu, Yan, Lizhi Cao, Liangchun Yang, et al.. (2012). microRNA30Apromotes autophagy in response to cancer therapy. Autophagy. 8(5). 853–855. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ding‐Sheng Jiang Breakdown of academic impact, for papers by Fei Quan Breakdown of academic impact, for papers by Jianjun Zhu Breakdown of academic impact, for papers by Rachida S. BelAiba Breakdown of academic impact, for papers by Sangbin Lim Breakdown of academic impact, for papers by Gabrielle Paulsson‐Berne Breakdown of academic impact, for papers by Tomonori Sasahira Breakdown of academic impact, for papers by Zhenyu Cai
Rankless by CCL
2026